期刊文献+

婴幼儿特发性血小板减少性紫癜临床特点及不同治疗方案分析 被引量:3

下载PDF
导出
摘要 目的探讨婴幼儿特发性血小板减少性紫癜(ITP)临床特点并分析不同治疗方案的疗效。方法对我院2007年2月~2010年2月收治的63例3岁以下ITP患儿的临床特征、诊断、治疗进行回顾性分析。结果所有ITP患儿中,显效56例,良效4例,进步4例。3例患儿常规减量时出现血小板波动,改用地塞米松并逐渐减量后获显效;4例患儿治疗期间病情出现反复,血小板相关免疫球蛋白PAIgG、PAIgM出现升高,加用免疫抑制剂后2例获显效,1例良效,1例进步。结论 ITP患儿具有如下临床特点:①婴幼儿发病率较高;②发病因素多;③聚合细胞成熟障碍;④糖皮质激素和丙种球蛋白是目前治疗ITP的主要有效手段。
作者 刘德新
出处 《临床和实验医学杂志》 2010年第22期1719-1720,共2页 Journal of Clinical and Experimental Medicine
  • 相关文献

参考文献4

二级参考文献19

  • 1[1]McMillan R.Autoantibodies and autoantigens in chronic immune thrombocytopenic purpura. Semin Hematol,2000,37:239
  • 2[2]Beardsley DS, Ertem M. Platelet autoantibodies in immune thrombocytopenic purpura. Transfus Sci,1998,19:237
  • 3[3]Mcfarl J. Pathophysiology of platelet destruction in immune (idiopathic) thrombocytopenic purpura. Blood Rev, 2002.16
  • 4[4]Semple JW. Immune pathophysiology of autoimmune thrombocytopenic purpura. Blood Rev,2002,16:9
  • 5[5]Semple JW, Milev Y, Cosgrave D, et al. Differences in serum cytokine levels in acute and chronic autoimmune thrombocytopenic purpura: relationship to platelet phenotype and antiplatelet T-cell reactivity. Blood,1996,87:4245
  • 6[6]Gernsheimer T. Pathophysiology and thrombokinetics in autoimmune thrombocytopenia. Blood Rev,2002,16:7
  • 7[7]Chong BH, Keng TB. Advances in the diagnosis of idiopathic thrombocytopenic purpura. Semin Hematol,2000,37:249
  • 8[8]George JN, Woolf SH, Raskob GE, et al. Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology. Blood,1996,88:3
  • 9[9]Tarantino MD. Acute immune (idiopathic) thrombocytopenic purpura in children. Blood Rev, 2002,16:19
  • 10[10]Blanchette V.Childhood chronic immune thrombocytopenic purpura (ITP). Blood Rev,2002,16:23

共引文献277

同被引文献28

  • 1朱雄鹏,陈志哲,张奕加,陈丽娟,刘德斌,周琳瑛,许文前,孙力,骆云龙.特发性血小板减少性紫癜治疗前后巨核细胞的改变及其意义[J].中国现代医学杂志,2004,14(23):101-102. 被引量:5
  • 2张根红,吴长根,王向红,张公惠,高巧娣,陆凤娟.静脉丙球治疗特发性血小板减少性紫癜的临床观察[J].上海医科大学学报,1996,23(6):480-481. 被引量:4
  • 3孙风兰.静脉注射丙种球蛋白治疗特发性血小板减少性紫癜11例疗效观察[J].中国实用儿科杂志,1997,12(6):352-352.
  • 4中华医学会儿科学分会血液学组.特发性血小板减少性紫癜诊疗建议.中华儿科杂志,1998,37(1):50-51.
  • 5张之南,沈悌.血液病诊断和疗效标准[M].第3版.北京:科学出版社,2008:172.
  • 6Kehon JG, Murphy WG, Lucarelli A, et al.Aprospective compairison of four techniques for measuring pletet-associated IgG[J].Br J Haematol, 1989 (71): 97.
  • 7Mueller-Eckhardt C, Kayser W, Mersh-Baumert K, et al.The clinical significance of platelet-associated IgG:a study on 298 patients with various disorders{J].Br J Haematol, 1980 ( 46 ) : 123.
  • 8Baronci C , Pansini V, Funaro D,et al. Idiopathic thrombocy- topenic purpura (ITP) in children[J].Pediatr Blood Cancer, 2006,47 : 665-667.
  • 9Bredlau AL, Semple JW, Segel GB. Management of immune thrombocytopenic purpura in children: potential role of novel agents [J]. Paediatr Drugs, 2011,13(4) :213 -223.
  • 10Shahgholi E, Vosough P, Sotoudeh K, et al. Intravenous im mune globulin versus intravenous anti-D immune globulin for the treatment of acute immune thrombocytopenic purpura[J]. Indian J Pediatr,2008 ,75(12) : 1231 1235.

引证文献3

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部